Provention Bio Inc buy Chardan Capital
Start price
13.03.23
/
50%
€22.41
Target price
13.03.24
€23.30
Performance (%)
1.07%
End price
14.03.24
-
Summary
This prediction is currently being closed. With a performance of 1.07%, the BUY prediction by Chardan_Capital for Provention Bio Inc is trending in the right direction. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Provention Bio Inc | - | - | - |
| iShares Core DAX® | -1.226% | 2.804% | 14.933% |
| iShares Nasdaq 100 | -1.845% | 2.732% | 26.075% |
| iShares Nikkei 225® | -1.132% | -2.218% | 5.361% |
| iShares S&P 500 | -0.980% | 1.883% | 22.727% |
Comments by Chardan_Capital for this prediction
In the thread Provention Bio Inc diskutieren
Provention Bio, Inc. (NASDAQ: PRVB) had its price target lowered by analysts at Chardan Capital from $30.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PRVB provided by MarketBeat
In the thread Trading Provention Bio Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten